These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 22299822)
1. Endogenous expansion of regulatory T cells leads to long-term islet graft survival in diabetic NOD mice. Shi Q; Lees JR; Scott DW; Farber DL; Bartlett ST Am J Transplant; 2012 May; 12(5):1124-32. PubMed ID: 22299822 [TBL] [Abstract][Full Text] [Related]
2. Abrogation of recurrent autoimmunity in the NOD mouse: A critical role for host interleukin 4. Shi Q; Wang D; Hadley GA; Farber DL; Bartlett ST Surgery; 2006 Aug; 140(2):281-8. PubMed ID: 16904981 [TBL] [Abstract][Full Text] [Related]
3. Pancreatic islets induce CD4(+) [corrected] CD25(-)Foxp3(+) [corrected] T-cell regulated tolerance to HY-mismatched skin grafts. Yoon IH; Choi SE; Kim YH; Yang SH; Park JH; Park CS; Kim Y; Kim JS; Kim SJ; Simpson E; Park CG Transplantation; 2008 Nov; 86(10):1352-60. PubMed ID: 19034003 [TBL] [Abstract][Full Text] [Related]
4. Prevention of autoimmune islet allograft destruction by engraftment of donor T cells. Bartlett ST; Schweitzer EJ; Kuo PC; Johnson LB; Delatorre A; Hadley GA Transplantation; 1997 Jan; 63(2):299-303. PubMed ID: 9020334 [TBL] [Abstract][Full Text] [Related]
5. In Vivo Costimulation Blockade-Induced Regulatory T Cells Demonstrate Dominant and Specific Tolerance to Porcine Islet Xenografts. Wu J; Hu M; Qian YW; Hawthorne WJ; Burns H; Liuwantara D; Alexander SI; Yi S; O'Connell PJ Transplantation; 2017 Jul; 101(7):1587-1599. PubMed ID: 27653300 [TBL] [Abstract][Full Text] [Related]
6. Long-term islet graft survival in NOD mice by abrogation of recurrent autoimmunity. Shi Q; Wang D; Hadley GA; Bingaman AW; Bartlett ST; Farber DL Diabetes; 2004 Sep; 53(9):2338-45. PubMed ID: 15331543 [TBL] [Abstract][Full Text] [Related]
7. Autoreactive effector/memory CD4+ and CD8+ T cells infiltrating grafted and endogenous islets in diabetic NOD mice exhibit similar T cell receptor usage. Diz R; Garland A; Vincent BG; Johnson MC; Spidale N; Wang B; Tisch R PLoS One; 2012; 7(12):e52054. PubMed ID: 23251685 [TBL] [Abstract][Full Text] [Related]
8. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells. Mellanby RJ; Thomas D; Phillips JM; Cooke A Immunology; 2007 May; 121(1):15-28. PubMed ID: 17428252 [TBL] [Abstract][Full Text] [Related]
9. CCL22 Prevents Rejection of Mouse Islet Allografts and Induces Donor-Specific Tolerance. Montane J; Obach M; Alvarez S; Bischoff L; Dai DL; Soukhatcheva G; Priatel JJ; Hardenberg G; Levings MK; Tan R; Orban PC; Verchere CB Cell Transplant; 2015; 24(10):2143-54. PubMed ID: 26423995 [TBL] [Abstract][Full Text] [Related]
10. PLG scaffold delivered antigen-specific regulatory T cells induce systemic tolerance in autoimmune diabetes. Graham JG; Zhang X; Goodman A; Pothoven K; Houlihan J; Wang S; Gower RM; Luo X; Shea LD Tissue Eng Part A; 2013 Jun; 19(11-12):1465-75. PubMed ID: 23432371 [TBL] [Abstract][Full Text] [Related]
11. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice. Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475 [TBL] [Abstract][Full Text] [Related]
12. Alpha-Lipoic Acid Inhibits Spontaneous Diabetes and Autoimmune Recurrence in Non-Obese Diabetic Mice by Enhancing Differentiation of Regulatory T Cells and Showed Potential for Use in Cell Therapies for the Treatment of Type 1 Diabetes. Huang SH; Kuo SL; Chen SJ; Lin JR; Chen YW; Hong ZJ; Sytwu HK; Lin GJ Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163121 [TBL] [Abstract][Full Text] [Related]
13. Revealing the specificity of regulatory T cells in murine autoimmune diabetes. Spence A; Purtha W; Tam J; Dong S; Kim Y; Ju CH; Sterling T; Nakayama M; Robinson WH; Bluestone JA; Anderson MS; Tang Q Proc Natl Acad Sci U S A; 2018 May; 115(20):5265-5270. PubMed ID: 29712852 [TBL] [Abstract][Full Text] [Related]
14. Systemic transforming growth factor-beta1 gene therapy induces Foxp3+ regulatory cells, restores self-tolerance, and facilitates regeneration of beta cell function in overtly diabetic nonobese diabetic mice. Luo X; Yang H; Kim IS; Saint-Hilaire F; Thomas DA; De BP; Ozkaynak E; Muthukumar T; Hancock WW; Crystal RG; Suthanthiran M Transplantation; 2005 May; 79(9):1091-6. PubMed ID: 15880049 [TBL] [Abstract][Full Text] [Related]
15. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy. Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973 [TBL] [Abstract][Full Text] [Related]
16. β-cell-specific IL-2 therapy increases islet Foxp3+Treg and suppresses type 1 diabetes in NOD mice. Johnson MC; Garland AL; Nicolson SC; Li C; Samulski RJ; Wang B; Tisch R Diabetes; 2013 Nov; 62(11):3775-84. PubMed ID: 23884888 [TBL] [Abstract][Full Text] [Related]
17. Encapsulated piscine (tilapia) islets for diabetes therapy: studies in diabetic NOD and NOD-SCID mice. Safley SA; Cui H; Cauffiel SM; Xu BY; Wright JR; Weber CJ Xenotransplantation; 2014; 21(2):127-39. PubMed ID: 24635017 [TBL] [Abstract][Full Text] [Related]